Venteze 2 mg & 4 mg (Tablet & Syrub)

Venteze 2 mg & 4 mg (Tablet & Syrub)

S2
PDF Leaflet Revision Date: 06 June 2022

API: Salbutamol | Company: Pharmacare

Clinical Summary

Quick overview from the medicine insert

Indication

Bronchodilator for bronchospasm in asthma, emphysema, and chronic bronchitis.

Dosage (summary)

Adults: 2-4 mg three to four times daily; Syrup: 5-10 ml three to four times daily.

Special Populations

  • Elderly: lower initial dose
  • Children under 2 years: safety not established

Pregnancy & Breastfeeding

Use in pregnancy only if essential; caution in breastfeeding.

Key Drug Interactions

  • Propranolol
  • Digoxin
  • MAOIs
  • Halogenated anaesthetics

Contraindications

  • Hypersensitivity to salbutamol
  • Concurrent use with beta-blockers
  • Hyperthyroidism
  • Cardiac disease

Common side effects

  • Tremor
  • Palpitations
  • Headache
  • Nausea

Counselling Points

  • Monitor for worsening asthma
  • Avoid driving if affected
  • Report any adverse reactions

Serious warnings

  • Tolerance may develop
  • Risk of hypokalaemia
  • Caution in cardiovascular disease
Important Disclaimer

The Venteze 2 mg & 4 mg (Tablet & Syrub) professional information leaflet below is the property of Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites